Navellier & Associates Inc Novo Nordisk A S Transaction History
Navellier & Associates Inc
- $792 Million
- Q4 2024
A detailed history of Navellier & Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Navellier & Associates Inc holds 5,082 shares of NVO stock, worth $439,186. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,082
Previous 118,465
95.71%
Holding current value
$439,186
Previous $14.1 Million
96.9%
% of portfolio
0.06%
Previous 2.0%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
322MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.72 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.24 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.24 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.09 Billion0.44% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.06 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $195B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...